Zoetis completes acquisition of Nexvet BiopharmaAugust 8, 2017Zoetis Inc., manufacturer of veterinary vaccines and medicines for veterinarians, livestock producers, farmers, and pet owners, announced the completion of its $85 million acquisition of Nexvet Biopharma, a Tullamore, Ireland-based company that manufactures monoclonal antibodies (mAb) for companion animal pain management.
Education Center - SponsoredBringing specialist level interpretation in-clinicby • Zoetis DiagnosticsImagine a busy weekday morning in a typical small animal clinic. The appointments are fully booked, the phones are ringing, and in comes Yogi, a five year old terrier mix whose owners are clearly worried.
